Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
12/21/1993 | US5272271 Pyranobenzoxadiazole derivatives |
12/21/1993 | US5272161 Indolesulphonamide-substituted dihydropyridines |
12/21/1993 | US5272147 Pyrazolopyrimidinone antianginal agents |
12/21/1993 | CA2098779A1 Phenyl-1,2,5-oxadiazolecarboxamide-2-oxides |
12/19/1993 | CA2098535A1 Linear peptides |
12/19/1993 | CA2096667A1 Method for preparing 7-oxabicycloheptyl substituted oxazole amide prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds |
12/18/1993 | CA2098562A1 Piperazine and homopiperazine derivatives, pharmaceutical compositions containing them and process for preparing the same |
12/18/1993 | CA2098473A1 Imidazopyridines |
12/18/1993 | CA2098366A1 Substituted (benzothiazolyl- and quinoxalyl-methoxy) phenyl-acetic acid derivatives |
12/15/1993 | EP0574312A1 Diacylglycerol nicotinates, processes for their preparation and pharmaceutical compositions containing them |
12/15/1993 | EP0574221A1 Pharmaceutical stable formulations of nicorandil |
12/15/1993 | EP0574174A2 Angiotensin II antagonists |
12/15/1993 | EP0573829A1 Pyrimidofuroxanes and their use as pharmacological agents |
12/15/1993 | EP0573510A1 Anti-growth factor antibodies in the treatment of vascular stenosis |
12/15/1993 | EP0550737A4 Controlled release verapamil tablet |
12/15/1993 | CN1079474A Stable salts of (+)-(1S,2R)-2-||N-(2-hydroxylamino-2-oxoethyl)-N-methyl-amino¨ carbonyl¨ cyclohexane-1-carboxylic acid, process for their preparation and pharmaceutical compositions containing them |
12/15/1993 | CN1079470A Û(Benzodioxan, benzofuran or benzopyran) alkylaminoÙ alkyl substituted guanidines |
12/15/1993 | CN1079468A Sulfonamide endothelin antagonists |
12/15/1993 | CN1079466A 4- or 5-(thio)acylimino- and (Sulfinyl) amidopyridine and their pyrindine-N-oxide |
12/14/1993 | US5270322 Imidazo[1,2-a]pyridines, pharmaceutical compositions containing these compounds and processes for preparing them |
12/14/1993 | US5270316 Condensed purine derivatives |
12/14/1993 | US5270313 Treatment of circulatory disorders |
12/14/1993 | US5270312 Substituted piperazines as central nervous system agents |
12/14/1993 | US5270311 [1,2,4]-Triazolo[1,5-a]and pyrazolo[2,3-a][1,3,5]triazine derivatives |
12/14/1993 | CA2098243A1 Benzimidazole derivatives |
12/14/1993 | CA1325213C Prodrug derivatives of the cardiotonic agent 4-ethyl- 1,3-dihydro-5-¬4-(2-methyl-1h-imidazol-1- yl)benzoyl|-2h-imidazol-2-one |
12/14/1993 | CA1325209C Certain 2-substituted adenosine derivatives |
12/14/1993 | CA1325153C Method of reendothelializing vascular linings |
12/12/1993 | CA2098168A1 Hydroxamic acid derivatives |
12/11/1993 | CA2098058A1 Fused 1,2,5-oxadiazole-2-oxides |
12/11/1993 | CA2098056A1 Pyrimidofuroxans |
12/10/1993 | CA2098069A1 Diacylglycerol nicotinates, their preparation process and pharmaceutical compositions containing the same |
12/09/1993 | WO1993024614A1 Antibodies with specificity for multiple adhesion molecules |
12/09/1993 | WO1993024530A1 Serum amyloid a protein |
12/09/1993 | WO1993024529A1 Retinal pigmented epithelium derived neurotrophic factor |
12/09/1993 | WO1993024527A1 Peptide inhibitors of selectin binding |
12/09/1993 | WO1993024521A1 Bpc peptides, their preparation and use |
12/09/1993 | WO1993024491A1 Indolocarbazole imides and their use |
12/09/1993 | WO1993024486A1 Quinuclidine derivatives as squalene synthetase inhibitors |
12/09/1993 | WO1993024473A1 7-(2-aminoethyl)-benzothiazolones |
12/09/1993 | WO1993024462A1 Substituted-hexahydrobenzo[a]phenanthridines |
12/09/1993 | WO1993024461A1 Tetrahydro and perhydro isoquinolin derivatives and therapeutic agents containing them |
12/09/1993 | WO1993024458A1 New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (acat) |
12/09/1993 | WO1993024149A1 Pharmaceutical powder composition containing non-ionic cellulose ether derivative and a chitin-derived polymer |
12/09/1993 | WO1993024143A1 A method for using lipoprotein associated coagulation inhibitor to treat sepsis |
12/09/1993 | WO1993024126A1 Substituted arginines and substituted homoarginines and use thereof |
12/09/1993 | WO1993024122A1 Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension |
12/09/1993 | WO1993014750A3 Amino acids useful as inhibitors of the advanced glycosylation of proteins |
12/09/1993 | CA2136719A1 Serum amyloid a protein |
12/09/1993 | CA2136449A1 Tetrahydro- and perhydroisoquinoline derivatives and therapeutic compositions containing these |
12/09/1993 | CA2136428A1 Peptide inhibitors of selectin binding |
12/09/1993 | CA2136205A1 Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension |
12/08/1993 | EP0573271A1 Angiotensin II antagonists |
12/08/1993 | EP0573260A1 New alkaloid derivatives, their use and pharmaceutical formulations containing them |
12/08/1993 | EP0573221A1 The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy |
12/08/1993 | EP0573218A2 4-Carboxyimidazoles as angiotensin II antagonists and their thrapeutic use |
12/08/1993 | EP0572952A1 4-Benzylpiperidine derivatives, a process for preparing them and pharmaceutical compositions containing them |
12/08/1993 | EP0572922A1 Synergistic combinations comprising lipoic acid and vitamines in medicaments |
12/08/1993 | EP0572909A1 Amino acid derivatives as renin inhibitors |
12/08/1993 | EP0572688A1 Peptides with organo-protective activity, the process for preparing them and their use in therapy |
12/08/1993 | EP0572560A1 Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology |
12/08/1993 | EP0572553A1 Recombinant thrombin receptor and related pharmaceuticals |
12/08/1993 | EP0572505A1 Human platelet-derived growth factor receptors |
12/08/1993 | EP0572455A1 Substituted pyridinones and pyrimidinones as angiotensin ii antagonists |
12/08/1993 | EP0480983B1 Use of peroxidated lipids for the preparation of medication to be used in the treatment, by local application, of circulation deficiencies |
12/08/1993 | EP0417129B1 Lung growth stimulatory and inhibitory factors for carcinoma tumor cells |
12/07/1993 | US5268384 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors |
12/07/1993 | US5268377 Imidazoindolizine derivatives process for preparation thereof and use thereof to treat hypertension |
12/07/1993 | US5268375 Dinitrogen heterocyclic derivatives N-substituted by a biphenylmethyl group, and the pharmaceutical compositions in which they are present |
12/07/1993 | US5268361 Hydroxyazido derivatives and related compounds as renin inhibitors |
12/07/1993 | CA1325009C P-hydroxy phenone derivatives and the use thereof |
12/06/1993 | CA2097766A1 Pyridyl-1,2,5-oxadiazolecarboxamide-2-oxides |
12/05/1993 | CA2097671A1 Heterocyclic derivatives |
12/05/1993 | CA2095671A1 Amino acid derivatives |
12/04/1993 | CA2097462A1 Angiotensin ii antagonists |
12/04/1993 | CA2097460A1 Angiotensin ii antagonists |
12/02/1993 | DE4217964A1 Indolocarbazol-Imide und deren Verwendung Indolocarbazole imides and the use thereof |
12/01/1993 | EP0572308A2 Heterocyclic derivatives, process for their preparation and pharmaceutical compositions containing them |
12/01/1993 | EP0571928A1 Acyclic Tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia |
12/01/1993 | EP0571822A1 Diazabicycloalkene derivatives |
12/01/1993 | EP0571795A1 Novel 3-phenyl-1,2,5-oxadiazoles and their use in the treatment of cardiovascular disorders, in particular angina pectoris and erectile dysfunction |
12/01/1993 | EP0571671A1 A Pharmaceutical composition in powder form |
12/01/1993 | EP0571613A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
12/01/1993 | EP0571602A1 Dimer of molecular variant of apolipoprotein and processes for the production thereof |
12/01/1993 | EP0406324B1 Hematopoietic colony-stimulating factors improve the lipoprotein cholesterol profile |
12/01/1993 | CN1022917C Process for 2-amino-tetrahydro-isoquinoline derivatives |
11/30/1993 | US5266591 Ethanolamine benzoate compounds |
11/30/1993 | US5266578 Lipoxygenase inhibitors |
11/30/1993 | US5266571 Treatment of hemorrhoids with 5-HT2 antagonists |
11/30/1993 | CA2097258A1 Phenylfuroxans |
11/30/1993 | CA2096496A1 Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia |
11/30/1993 | CA1324793C 17-aza derivatives of 20, 21-dinoreburnamenine, process for their preparation and their intermediates, their application as medecines and compositions containing them |
11/26/1993 | CA2096804A1 Heterocyclic derivatives, method of preparation thereof and pharmaceutical compositions which contain them |
11/25/1993 | WO1993023428A1 Calcium channel blocking polypeptides from filistata hibernalis |
11/25/1993 | WO1993023418A1 Purine derivatives |
11/25/1993 | WO1993023417A1 Novel adenosine derivatives |
11/25/1993 | WO1993023403A1 NOVEL MERCAPTOACETYLAMIDO PYRIDAZO[1,2]PYRIDAZINE, PYRAZOLO[1,2]PYRIDAZINE, PYRIDAZO[1,2-a][1,2]DIAZEPINE AND PYRAZOLO[1,2-a][1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE |
11/25/1993 | WO1993023399A1 6-AMINO SUBSTITUTED IMIDAZO[4,5-b]PYRIDINES AS ANGIOTENSIN II ANTAGONISTS |
11/25/1993 | WO1993023397A1 4-mercaptoacetylamino-[2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors |
11/25/1993 | WO1993023395A1 Heteroaromatic quinuclidinenes, their use and preparation |